Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 953 of 1,261

  1. US 8007804

    Complement receptor 2 targeted complement modulators

    The Regents of the University of Colorado · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  2. US 8008308

    Phosphonate compounds

    The Regents of the University of California · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  3. US 8008038

    Methods for determining oxygen concentration with protoporphyrin IX

    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  4. US 8008021

    N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease

    Evanston Northwestern Healthcare · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  5. US 8008435

    Polymer stabilized neuropeptides

    Nektar Therapeutics · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  6. US 8008501

    Quinoline compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  7. US 8008316

    Azonafide derived tumor and cancer targeting compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  8. US 8008332

    Substituted indazoles as glucokinase activators

    Takeda San Diego, Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  9. US 8008353

    Methods for modulating macrophage proliferation using polyamine analogs

    The Regents of the University of California · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  10. US 2011206613

    METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT

    WIEHE ARNO [DE] · Granted Aug 25, 2011 · Expires Aug 20, 2031

    granted

  11. US 8003619

    Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide

    Alnylam Pharmaceuticals, Inc. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  12. US 8003103

    High affinity human antibodies to human IL-18 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  13. US 8003685

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  14. US 8003764

    Folliculin-specific antibodies and methods of detection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  15. US 8003126

    Stable tablet formulation

    BIOMARIN PHARMACEUTICAL INC. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  16. US 8001922

    Application of a coating on a medical device

    ATRIUM MEDICAL CORPORATION · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  17. US 8003091

    Pharmaceutical compositions comprising purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  18. US 8003112

    Meningococcal and pneumococcal conjugate vaccine and method of using same

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  19. US 8003755

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Theravance, Inc. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  20. US 8003785

    Halo-substituted pyrimidodiazepines

    Takeda Pharmaceutical Company Limited · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  21. US 8003406

    Methods for detecting attention-deficit/hyperactivity disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  22. US 8003660

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  23. US 8003629

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  24. US 8003622

    Peptide biosynthesis and pain therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.